Brief: Novabay Pharmaceuticals Announces $3 Million Convertible Note Financing
27/04/2023 21:54
April 27 (Reuters) - NovaBay Pharmaceuticals Inc
NBY.A :
* NOVABAY PHARMACEUTICALS ANNOUNCES $3.0 MILLION CONVERTIBLE
NOTE
FINANCING
Source text for Eikon: ID:nBw8m8WgPa
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing